|
[1]
|
Analytical Technique for Carvedilol and Ivabradine determination from pure and Pharmaceutical Dosage Forms: A Review
Asian Journal of Pharmaceutical Analysis,
2023
DOI:10.52711/2231-5675.2023.00020
|
|
|
|
|
[2]
|
Development and Validation of a Rapid Analytical Method for the Simultaneous Quantification of Metabolic Syndrome Drugs by HPLC-DAD Chromatography
Scientia Pharmaceutica,
2021
DOI:10.3390/scipharm89010008
|
|
|
|
|
[3]
|
Development and Validation of a Rapid Analytical Method for the Simultaneous Quantification of Metabolic Syndrome Drugs by HPLC-DAD Chromatography
Scientia Pharmaceutica,
2021
DOI:10.3390/scipharm89010008
|
|
|
|
|
[4]
|
Temperature and eluent composition effects on enantiomer separation of carvedilol by high-performance liquid chromatography on immobilized amylose-based chiral stationary phases
Journal of Pharmaceutical Analysis,
2019
DOI:10.1016/j.jpha.2019.04.002
|
|
|
|
|
[5]
|
Development and validation of UPLC method for simultaneous quantification of carvedilol and ivabradine in the presence of degradation products using DoE concept
Journal of Liquid Chromatography & Related Technologies,
2018
DOI:10.1080/10826076.2018.1427595
|
|
|
|
|
[6]
|
Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
Natural Products and Bioprospecting,
2017
DOI:10.1007/s13659-016-0118-2
|
|
|
|